Virtual immunohistochemistry for ER and PR prediction in breast cancer histopathology: a two-stage conditional generative framework
Background Immunohistochemistry (IHC) remains the gold standard for assessing key breast cancer biomarkers such as estrogen receptor (ER) and progesterone receptor (PR). However, the staining process is resource-intensive, time-consuming, and dependent on specialized laboratory infrastructure. While recent advances in...